Friday, September 11, 2009 9:07:49 AM
Indivlnvestor, good points all! I agree with 90%. However, I do not agree with just giving management a ridiculously large management reserve of authorized shares without a sufficient reason. Roughly speaking, (from memory) OXBO has 300M shares issued, and about 100M in A/S.
The 100M in A/S is currently valued at $43M (100,000,000 x .43 = 43,000000). After the split the A/S will be valued at $645M. (.43 X 15 = 6.45 X 100,000,000 = 645,000,0000)
Management needs to make me understand why then need $645M (today’s value) in A/S when the market cap is $127M.
I like this management team, and I’m not implying that that will abuse this power. But the shareholders would be giving up the hammer.
I’m still half asleep, so if I botched the numbers I’m sorry.
The 100M in A/S is currently valued at $43M (100,000,000 x .43 = 43,000000). After the split the A/S will be valued at $645M. (.43 X 15 = 6.45 X 100,000,000 = 645,000,0000)
Management needs to make me understand why then need $645M (today’s value) in A/S when the market cap is $127M.
I like this management team, and I’m not implying that that will abuse this power. But the shareholders would be giving up the hammer.
I’m still half asleep, so if I botched the numbers I’m sorry.
Recent TENX News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/20/2026 09:05:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 10:55:54 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:26:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:31:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 09:08:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:56:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/12/2026 09:01:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:06:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 12:00:07 PM
- Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/12/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 10:19:02 PM
- Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/08/2026 08:05:00 PM
- Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer • GlobeNewswire Inc. • 05/04/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:19:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:17:37 PM
